Longitudinal observation of a sample of german drug consumption facility clients

Substance Use and Misuse

Volumn 45, Issue 1-2, 2010, Pages 176-189

  Scherbaum, Norbert ^a   Specka, Michael ^a   Schifano, Fabrizio ^b   Bombeck, Johannes ^c   Marrziniak, Bärbel ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c Suchthilfe Direkt   (Germany)

Author keywords

Drug consumption facility; Harm reduction; Intravenous drug abuse; Opiate addiction

Indexed keywords

ADULT; COUNSELING; DRUG USERS; FEMALE; GERMANY; HUMANS; LONGITUDINAL STUDIES; MALE; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENTS; REFERRAL AND CONSULTATION; RISK-TAKING; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME;

EID: 73649100245     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826080902873044     Document Type: Article

References (22)

1. Bammer, G. (2000). What can a trial contribute to the debate about supervised injecting rooms? Australian and New Zealand Journal of Public Health, 24:214-215.
2. Benninghoff, F., Dubois-Arber, F. (2002). Ŕesultats De l'́etude De La client̀ele du Cactus Biel/Bienne (Results of research about the clients of Cactus Biel). Lausanne: Institut Universitaire De Medecine Sociale et Preventive.
3. De La Fuente, L., Brugal, M. T., Domingo-Salvany, A., Bravo, M. J., Neira-Leon, M., Barrio, G. (2006). More than thirty years of illicit drugs in Spain: a bitter story with some messages for the future. Revista Española De Salud Ṕublica, 80:505-520.
4. Deutsche Gesellschaft fuer Suchtforschung und Therapie e.V. (Eds.). (2001). Dokumentations standards III fuer die Evaluation der Behandlung von Abḧangigen (Documentation standards III for the evaluation of addiction treatments). Sucht 47, Sonderheft Nr. 2, 3-94.
5. Dietze, P., Jolley, D., Fry, C., Bammer, G. (2005). Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction, 100:636-642.
6. Fry, C., Fox, S., Rumbold, G. (1999). Establishing safe injecting rooms in Australia: attitudes of injecting drug users. Australian and New Zealand Journal of Public Health, 23:501-504.
7. Gsellhofer,B.,K̈ufner, H.,Vogt,M.,Weiler, D. (1999). European Addiction Severity Index: EuropASI. Baltmannsweiler: Schneider Verlag Hohengehren.
8. Happel, H. V. (2000). Konsumr̈aume-Eine effektive Maßnahme zur Schadens-minimierung bei DrogengebraucherInnen und B̈urgerInnen (Drug consumption rooms-an effective measure for harm reduction in drug users and citizens). FrankFurt: Fach-hochschule FrankFurt.
9. Hedrich, D. (2004). European report on drug consumption rooms. Office for Official Publications of the European Communities, Luxembourg.
10. Kleiber, D., Pant, A. (1999). Die Rolle psychosozialer Indikatoren im Rahmen von Modellprojekten zur medizinisch kontrollierten Heroinvergabe (The role of psychosocial indicators within the framework of medically controlled heroin dispensation). In B. Westermann, G. Bellmann, & C. Jellinek (Eds.), Heroinverschreibung. Wirkungen und Nebenwirkungen (pp. 47-53). Weinheim: Beltz Deutscher Studien Verlag.
11. Landesregierung Nordrhein-Westfalen. (2000). Verordnung ̈uber den Betrieb von Drogenkonsumr ̈aumen vom 26.9.2000 (Regulation for the operation of drug consumption rooms). Gesetzund Verordnungsblatt fuer das Land Nordrhein-Westfalen, 646-647.
12. MSIC Evaluation Committee. (2003). Final report of the evaluation of the Sydney Medically Supervised Injecting Centre, Sydney.
13. Perez Gonzalez, K., Domingo-Salvany, A., Hartnoll, R. (1999). The characteristics of opiate users seen in an emergency service. Gaceta Sanitaria, 13:88-95.
14. Poschadel, S., Ḧoger, R., Schnitzler, J., Schreckenberg, D. (2003). Evaluation der Arbeit der arbeit der Drogenkonsumr̈aume in der Bundesrepublik Deutschland. Endbericht im Auftrag es Bundesministeriums f̈ur gesundheit. Schriftenreihe des Bundesministeriums f̈ur gesundheit und Soziale Sicherung, n. 149, Nomos-Verlagsgesellschaft, Baden-Baden.
15. Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., et al. (2006). Public injecting and the need for "safer environment interventions" in the reduction of drug-related harm. Addiction, 101:1384-1393.
16. Ronco, C., Spuhler, G., Coda, P., Schopfer, R. (1996). Evaluation of street facilities I, II and III in Basel. Sozial- und Pr̈aventivmedizin, 41(Suppl. 1):S58-S68.
17. Solai, S., Benninghoff, F., Meystre-Agustoni, G., Jeannin, A., Dubois-Arber, F. (2004). Evaluation De l'espace De l'accueil et d'injection "Quai 9" a Geneve: deuxieme phase 2003 (Evaluation of the drop-in centre and injection room "Quai 9" in Geneva: 2nd phase 2003). Lausanne: Institut Universitaire De Medecine Sociale et Preventive.
18. Van Der Poel, A., Barendregt, C., van De Mheen, D. (2003). Drug consumption rooms in Rotterdam: an explorative description. European Addiction Research, 9:94-100.
19. Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Kerr, T., Hogg, R. S., et al. (2001). Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? Canadian Medical Association Journal, 165:405-410.
20. Wright, N. M., Tompkins, C. N. (2006a). How can health services effectively meet the health needs of homeless people? The British Journal of General Practice, 56:286-289.
21. Wright, N. M., Tompkins, C. N. (2006b). A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users. Harm Reduction Journal, J3:27.
22. Zobel, F., Dubois-Arber, F. (2004). Kurzgutachten zu Rolle und Nutzen von Anlaufstellen mit Konsumraum (ASTK) in Bezug auf die Verminderung der Drogenprobleme in der Schweiz. Gutachten im Auftrag des Bundesamtes fuer Gesundheit (Short expertise on role and benefits of drop-in centres with consumption room, with respect to reduction of drug problems in Switzerland. Expertise by order of the federal health office). Lausanne: Institut Universitaire De Medecine Sociale et Preventive.